Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Nuvation Bio

585 Howard St. 3rd Floor
San Francisco, CA 94104
USA
Website Company Summary Management Team
Management

CEO: David T. Hung (7/31/2019)
General Management: Sergey Yurasov (9/30/2019)
Finance: Bina Motiram (9/30/2019)
Technology: Gary Hattersley (7/31/2019) ; Michele D. Bronson (7/31/2019)
Board

Outside board: (May no longer be on the board) Kim D. Blickenstaff (Biosite Former CEO) Michelle Doig (Omega Funds Partner) Richard Lim (Omega Funds Managing Director) Otello Stampacchia (Omega Funds Founder) W. Anthony Vernon (Kraft Foods Group Former CEO)
Company

Business description: Nuvation Bio is a privately-held biopharmaceutical company currently operating in stealth mode that is focused on the development of next generation therapies that will target the foremost unmet needs in oncology. Nuvation Bio’s proprietary portfolio includes seven novel and mechanistically distinct oncology programs, each with multiple drug development candidates. Nuvation Bio was founded in 2018 by industry veteran David Hung, M.D., who previously founded and served as President and Chief Executive Officer of Medivation. Nuvation Bio has offices in New York and San Francisco.
Capital

Rounds: 1
Recent Fundings: Oct 2019
Capital raised: 275.0M
Last Round: 275.0M
Ownership: Private  
VCs include: Altitude Life Science Ventures Aisling Capital Redmile Group ;  EDBI Fidelity Management and Research Company ;  Omega Funds ;  Surveyor Capital Perceptive Advisors ;  Boxer Capital of the Tavistock Group ;  Pavilion Capital
Private equity: The Baupost Group

Last Tweets


 

Last Mentions


Overview
Record updated: Oct 2020
Rounds: 1
Recent Fundings: Oct 2019
Capital Raised: 275.0M
Last Round: 275.0M
Ownership: Private